Continuous serratus plane block for thoracoscopic surgery

JRCT ID: jRCT1041220119

Registered date:18/01/2023

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: pulmonary nodules
• Date of first enrollment: 01/06/2021
• Target sample size: 30
• Study type: Interventional
• Intervention(s): continuous injection of ropivacaine into serratus muscles plane using epidural catheter.

Outcome(s)

• Primary Outcome: pain scale, adverse event
• Secondary Outcome: duration of analgesia, extirbation after extratubation

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: <= 90age old
• Gender: Both
• Include criteria: patients of pulmonary tumors using 3 ports thoracoscopic surgery, from 20 years-old to 90
• Exclude criteria: patients using anti-coagulation drugs

Related Information

• Primary Sponsor: Sekimura Atsushi